Earnings History for Salix Pharmaceuticals Ltd. (SLXP)
|
Expand Research on SLXP
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/13  |
 |
Q113 | $0.63 | $0.68 | -$0.05 | $202.6M | $205.94M | N/A / N/A | = | +8.5% | Details |
| 2/28/13 |
|
Q412 | $0.81 | $0.79 | +$0.02 | $198.2M | $199.41M | N/A / N/A | N/A | +20.3% | Details |
| 11/7/12 |
|
Q312 | $0.95 | $0.70 | +$0.25 | $185.1M | $187.63M | $0.83 / $191.5M |  |
+54.7% | Details |
| 8/8/12 |
Q212 | $0.79 | $0.55 | +$0.24 | $181M | $180.79M | N/A / N/A | |
+31.2% | Details | |
| 2/27/12 |
|
Q411 | $0.56 | $0.96 | -$0.40 | $155.2M | $152.62M | N/A / N/A | |
+27% | Details |
| 11/8/11 |
|
Q311 | $0.77 | $0.63 | +$0.14 | $146.2M | $140.56M | N/A / N/A | N/A | +67.9% | Details |
| 8/8/11 |
|
Q211 | $0.54 | $0.48 | +$0.06 | $133.2M | $131.52M | N/A / N/A | N/A | +77.6% | Details |
| 5/5/11 |
|
Q111 | $0.34 | $0.18 | +$0.16 | $105.9M | $108.73M | N/A / N/A | N/A | +54.2% | Details |
